Share-based Payment Arrangement, Noncash Expense of Deciphera Pharmaceuticals, Inc. from 31 Dec 2015 to 31 Mar 2024
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
Deciphera Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Dec 2015 to 31 Mar 2024.
- Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Mar 2024 was $10,174,000, a 19% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $50,603,000, a 2.6% decline from 2022.
- Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2022 was $51,942,000, a 13% increase from 2021.
- Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2021 was $46,078,000, a 24% increase from 2020.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
Deciphera Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2024 | $10,174,000 | -$2,340,000 | -19% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 10 May 2024 | 2024 | Q1 | |
| Q1 2023 | $12,514,000 | -$1,754,000 | -12% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 10 May 2024 | 2024 | Q1 | |
| Q1 2022 | $14,268,000 | +$3,149,000 | +28% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 03 May 2023 | 2023 | Q1 | |
| Q1 2021 | $11,119,000 | +$4,125,000 | +59% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 04 May 2022 | 2022 | Q1 | |
| Q1 2020 | $6,994,000 | +$765,000 | +12% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 04 May 2021 | 2021 | Q1 | |
| Q1 2019 | $6,229,000 | +$4,192,000 | +206% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 05 May 2020 | 2020 | Q1 | |
| Q1 2018 | $2,037,000 | +$1,621,000 | +390% | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 09 May 2019 | 2019 | Q1 | |
| Q1 2017 | $416,000 | 01 Jan 2017 | 31 Mar 2017 | 10-Q | 08 May 2018 | 2018 | Q1 |
Deciphera Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | $50,603,000 | -$1,339,000 | -2.6% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2022 | $51,942,000 | +$5,864,000 | +13% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2021 | $46,078,000 | +$8,941,000 | +24% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2020 | $37,137,000 | +$16,727,000 | +82% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 07 Feb 2023 | 2022 | FY |
| 2019 | $20,410,000 | +$10,722,000 | +111% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 08 Feb 2022 | 2021 | FY |
| 2018 | $9,688,000 | +$4,822,000 | +99% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 09 Feb 2021 | 2020 | FY |
| 2017 | $4,866,000 | +$3,379,000 | +227% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 09 Mar 2020 | 2019 | FY |
| 2016 | $1,487,000 | -$1,070,000 | -42% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 14 Mar 2019 | 2018 | FY |
| 2015 | $2,557,000 | 01 Jan 2015 | 31 Dec 2015 | 10-K | 28 Mar 2018 | 2017 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.